Suda Pharmaceuticals (ASX:SUD) Share Price and News

Market Cap (24-Dec) $23,079,360 (1,609th)	Close (25-Oct) $0.048 0 (0%)	Volume (25-Oct) 0	Shortsold (25-Jun) 3,768 (0.00%) (647th)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.019

	Subject
	SUD SUD Ann: SUDA becomes Arovella Therapeutics
	1 (current) 2 3
	SUD SUD Ann: Chile Ministry of Health Approval Granted for ZolpiMist
	SUD SUD Ann: Results of General Meeting
	SUD SUD Ann: GM presentation
	SUD SUD Ann: Appendix 4G and Corporate Governance Statement 2021
	SUD SUD Ann: Annual Report to shareholders
	SUD SUD Ann: Notice of Extraordinary General Meeting/Proxy Form
	SUD SUD Ann: Investor Presentation
	SUD SUD Ann: Dr John Maher Appointed to SUDA iNKT Cell Therapy SAB
	SUD SUD Ann: Preliminary Final Report
	SUD SUD Ann: Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SAB
	SUD SUD Ann: SUDA signs Licence and Distribution Agreement with STADA
	SUD SUD Ann: ZolpiMist Update
	SUD SUD Ann: iNKT cell therapy platform update
	SUD SUD Ann: Initial Director's Interest Notice
	SUD SUD Ann: Appointment of Dr Debora Barton as Non-Executive Director
	SUD SUD Ann: SUDA appoints new cell and gene therapy manufacturing expert
	SUD SUD Ann: SUDA to present at NWR Virtual Investor Conference
	SUD SUD Ann: Quarterly Appendix 4C and Activities Report
	SUD SUD Ann: Notification regarding unquoted securities - SUD
	SUD SUD Ann: Application for quotation of securities - SUD
	SUD SUD Ann: Proposed issue of securities - SUD
	SUD SUD Ann: Disclosure Document Prospectus $3.65m
	SUD SUD Ann: Proposed issue of securities - SUD
	SUD SUD Ann: SUDA Placement Raises $3.65m
	SUD SUD Ann: Investor Webinar
	SUD SUD Ann: Investor Presentation incorporating iNKT Cell Platform
	SUD SUD Ann: SUDA Licenses a Novel iNKT Cell Therapy Platform
	SUD SUD Ann: Trading Halt
	SUD SUD Ann: Quarterly Appendix 4C and Activities Report
	SUD SUD Ann: Anagrelide Project Update
	SUD SUD Ann: Investor Presentation March 2021
	SUD SUD Ann: Newsletter March 2021
	SUD SUD Ann: Anagrelide Project Update
	SUD SUD Ann: Appendix 3G
	SUD SUD Ann: Anagrelide Project Update
	SUD SUD Ann: Appendix 4D & Interim Financial Half Year Report FY2021
	SUD SUD Ann: Change of Director's Interest Notice
	SUD SUD Ann: Change of Director's Interest Notice
	SUD SUD Ann: Change of Director's Interest Notice
	SUD SUD Ann: Appendix 2A
	SUD SUD Ann: Zelira Therapeutics Feasibility Study Update
	SUD SUD Ann: Results of General Meeting
	SUD SUD Ann: GM presentation
	SUD SUD Ann: Quarterly Appendix 4C and Activities Report
	SUD SUD Ann: Zolpimist Update
	SUD SUD Ann: Suda Update
	SUD SUD Ann: Notice of EGM and Proxy form
	SUD SUD Ann: Placement Offer Completed and Appendix 2A
	SUD SUD Ann: Proposed issue of Securities - SUD

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
24-Dec	$0.04	61,565	+0.00 (2.78%)
23-Dec	$0.04	0	0.00 (0.00%)
22-Dec	$0.04	240,705	0.00 (0.00%)
21-Dec	$0.04	1,314,424	0.00 (2.70%)
17-Dec	$0.04	505,348	0.00 (7.50%)
16-Dec	$0.04	285,040	0.00 (0.00%)
15-Dec	$0.04	2,549,396	+0.00 (8.11%)
14-Dec	$0.04	632,378	0.00 (7.50%)
13-Dec	$0.04	1,700,475	+0.00 (14.29%)
10-Dec	$0.04	58,711	0.00 (0.00%)
09-Dec	$0.04	441,485	0.00 (0.00%)
08-Dec	$0.04	1,557,718	0.00 (0.00%)
07-Dec	$0.04	8,000	0.00 (2.78%)
06-Dec	$0.04	830,902	+0.00 (2.86%)
03-Dec	$0.04	147,901	0.00 (0.00%)
4 up, 4 down, and 7 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
26 April 2025 at 8:20pm

High -	Low -	Trades -	Turnover $0	Volume 0
26 April 2025 at 8:20pm

Suda Pharmaceuticals Health Care

$0.048 (0%)

$0.048 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

SUD Suda Pharmaceuticals Health Care

$0.048 (0%)

$0.048 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Suda Pharmaceuticals Health Care